Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies

View source ↗

Summary

This clinical trial investigates nusinersen (Spinraza) exposure before or during pregnancy in people with spinal muscular atrophy and assesses the health outcom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spinraza (nusinersen)

Snippet

Sponsor: Biogen | Conditions: Muscular Atrophy, Spinal | Status: RECRUITING